Allied Market Research reports that the global healthcare information technology (IT) market size was valued at $250,577.15 million in 2020, and is projected to reach $880,688.75 million by 2030, registering a CAGR of 13.3% from 2021 to 2030.
Data Bridge Market Research reports the market drivers and growth can be attributed to the increase in technological know-how, growing volume of patient data, and demand for quick and efficient healthcare processes and systems will help in driving the growth of the healthcare IT market. Increasing digitization in the healthcare industry and demand for value based care and rising cost of provision of healthcare services coupled with the increasing number of healthcare facilities will likely accelerate the growth of the healthcare IT market in the forecast period of 2020-2027.
Health IT Product News
Clarify Health Launches Generative Artificial Intelligence, Clara
Clarify Health (@ClarifyHealth), an innovative leader in healthcare analytics and value-based payment solutions, is thrilled to announce the closed beta launch of its revolutionary generative artificial intelligence (AI), Clara.
New Equality Health at Home Helps Complex Patients Navigate Healthcare System, Address SDoH and Reconnect to Primary Care Provider
Equality Health (@equalityhealth), a company in value-based care, announced its Equality Health at Home care program – an innovative initiative whereby on-staff community health workers, nurse practitioners, and chaplains deliver in-person and virtual care at home to patients facing complex medical issues and experiencing significant barriers to managing their health.
Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring
Know Labs (@TheKnowLabs), an emerging developer of non-invasive medical diagnostic technology, revealed the next stage in the development of its proprietary Bio-RFID™ technology – the Generation (Gen) 1 Device.
RxBenefits & RxPharmacy Assurance Announce Advancements in Specialty Cost & Risk Avoidance Solutions
RxBenefits (@rxbenefits), the employee benefits industry’s first technology-enabled pharmacy benefits optimizer (PBO), and its sister company, RxPharmacy Assurance, announced new enhancements to their product portfolio designed to improve health outcomes and reduce specialty drug costs for patients and plans.
Luma Health Debuts Digital Call Deflection To Reduce Hold Times, Inbound Calls With Self-Service SMS
Luma Health (@lumahealthhq) has launched a new Digital Call Deflection service to create a better experience for patients and reduce inbound call volume for staff by redirecting calls to self-service SMS. Luma Digital Call Deflection, now available to all health systems and clinics, helps short-staffed healthcare providers get patients to the next step in their care with a fast, easy, and customized self-service experience.
New Micro-Incentive Program Rewards Physicians for Referring to Higher-Value Specialists
Clarify Health (@ClarifyHealth), a healthcare analytics and value-based payments platform company, is pleased to announce its newest program to improve specialist referrals delivered through its Clarify Advance solution.
Remote Patient Monitoring Product News
ComForCare Establishes Exclusive Partnership with Connected Home Living to Launch Connected Care, Providing 24/7 Monitoring
ComForCare (@ComForcare), a franchised provider of in-home caregiving services, forges an exclusive partnership with Connected Home Living, a company in remote patient care, to introduce Connected Care for clients.
Southcoast Health implements a monitoring device called the Leaf Patient Monitoring System.
Southcoast Health’s Charlton Memorial Hospital (@SouthcoastHlth), St. Luke’s Hospital, and Tobey Hospital are among the first in Massachusetts to implement a unique monitoring device called the Leaf Patient Monitoring System, designed to assist with patient turning protocols and reduce the incidence of pressure injuries, commonly called bed sores, that can occur during long hospital stays.
AI Product News
ObjectiveHealth Launches ObjectiveScreen, an Artificial Intelligence-Powered Feasibility and Recruitment Platform to Optimize Clinical Trial Performance
ObjectiveHealth (@Objhealth), a Nashville-based integrated research and technology platform company, announced the launch of ObjectiveScreen, a cutting-edge artificial intelligence (AI) feasibility and recruitment platform that optimizes clinical trial performance and outcomes through superior patient identification, prequalification and retention.
LeanTaaS Announces iQueue Autopilot, First Ever Generative AI Hospital Operations Solution
LeanTaaS, Inc. (@LeanTaaS), a company providing AI-powered and SaaS-based capacity management, staffing, and patient flow software for health systems, announced the launch of iQueue Autopilot. This first-of-its-kind, generative AI solution for hospital operations will provide hospital leaders with human-like conversations and actionable insights to support decision-making for patient flow, scheduling, command center, block management, staffing, and other capacity management use cases across both inpatient and outpatient settings.
GE HealthCare Introduces Sonic DL: A Groundbreaking, FDA-Cleared AI Deep Learning Technology for Faster MRI
GE HealthCare (@GEHealthCare) announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate image acquisition in magnetic resonance imaging (MRI). Sonic DL enables new imaging paradigms, such as high-quality cardiac MRI in a single heartbeat. This breakthrough expands GE HealthCare’s industry-leading AI-enabled solutions portfolio.
Carbon Health Launches AI Charting in Its EHR Across All Clinics and Providers
Carbon Health (@CarbonHealth) announced the launch of hands-free charting — an AI-enabled notes assistant — in its proprietary EHR across each of its clinics and providers. Carbon Health’s EHR (electronic health records) platform is the first to deploy native AI-assisted charting at scale. With the patent-pending technology, Carbon Health has developed a way for providers to generate comprehensive and accurate medical notes more efficiently with the press of a record button.
Paige Introduces New AI-Based Biomarker Screening Advancement to Drastically Reduce Diagnostic Turnaround Times and Inform Precision Treatment Decisions
Paige (@paige_ai), a global company in end-to-end digital pathology solutions and clinical AI applications that assist in diagnosing cancer, announced a new AI-based digital assay to support pathologists in the detection and diagnosis of microsatellite instability (MSI) status in colon cancers. Paige Colon MSI operates on whole slide images of hematoxylin and eosin (H&E)-stained slides alone, offering slide-level classification of MSI status in colon cancer samples* based on morphologies associated with the presence or absence of MSI/MMR phenotype.
Tempus Announces Broad Launch of Tempus One
Tempus (@TempusLabs), a company in artificial intelligence (AI) and precision medicine, announced the upcoming broad launch of Tempus One – the first, AI-enabled clinical assistant that leverages advancements in generative AI to provide clinicians access to patient insights directly at their fingertips. Tempus One is a voice and text assistant – available via the Tempus Hub desktop and mobile app – that is designed to provide clinicians with quick access to their patient’s full clinical and molecular profile, along with an array of other datasets, which can be queried by physicians to help inform clinical decisions in real-time.
Esco Medical Selects Fairtility’s CHLOE EQ™ as AI Decision Support Tool for MIRI® Time-Lapse Incubators
Fairtility (@fairtility), the transparent AI innovator powering in vitro fertilization (IVF) for improved outcomes, announced that Esco Medical (@EscoMedical) has selected CHLOE EQ™ as the AI decision support tool to integrate with its MIRI® Time-Lapse Incubators (TLI). CHLOE EQ™ will provide its transparent AI embryo quality assessment capabilities, enabling explainable AI output to recommend embryos most likely to lead to implantation in an IVF cycle.
TeleVox Launches AI-Enabled Omnichannel Conversational Virtual Assistant for Healthcare Providers
TeleVox (@TeleVox_Health), a provider of omnichannel digital patient technology, unveiled its latest innovation at the HIMSS Conference this past April. Iris™, is the newest addition to the company’s end-to-end digital patient engagement platform, HouseCallsPro. Iris is a powerful AI-driven virtual agent accessible via web, voice and SMS interactions and embedded into HouseCalls Pro patient engagement workflows. Utilizing Microsoft Azure OpenAI Service with its large-scale, generative AI models and other chat technology, Iris provides patients with quick access to information and easy completion of common tasks, improving patient access and self-service.
FDA Medical Devices
Approved in April and May 2023
The FDA regulates medical devices sold in the United States to assure their safety and effectiveness. Medical devices range from simple tongue depressors and hospital gowns to complex programmable pacemakers and robotic surgical systems. Their Medical Device Product Classification database lists over 6,000 types of medical devices regulated by FDA’s Center for Medical Devices and Radiological Health (CDRH) and the classification assigned to each type. Depending on the device classification, along with other factors, federal regulations (such as the Code of Federal Regulations, Title 21) define requirements that must be fulfilled for CDRH to approve or clear devices sold in the United States.
Here are the recently approved devices for the months of April and May.